- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- F-1 Registration statement (foreign)
- 3.1 Amended and Restated Memorandum of Association
- 3.2 Amended and Restated Articles of Association
- 4.1 Specimen Certificate for Ordinary Shares
- 5.1 Form of Opinion of Ogier Regarding the Validity of the Ordinary Shares Being Registered
- 10.1 Form of Employment Agreement by and Between Executive Officers and the Registrant
- 10.2 Form of Indemnification Agreement with the Registrant's Directors and Officers
- 10.3 English Translation of the Working Capital Loan Contract Between Jiangxi Universe and Jiangxi Liuling Rural Commercial Bank Co., LTD., Dated June 26, 2019
- 10.4 English Translation of the Working Capital Loan Contract Between Universe Trade and Jiangxi Liuling Rural Commercial Bank Co., LTD., Dated September 26, 2019
- 10.5 English Translation of the Loan Guarantee Contract Among Jiangxi Universe, Xing Wu, Universe Trade, and Jiangxi Liuling Rural Commercial Bank Co., LTD., Dated September 26, 2019
- 10.6 English Translation of the Loan Guarantee Contract Among Gang Lai, Lin Yang, Jiangxi Universe, Foshan Shangyu Investment Holding Co., LTD., Fujing Wang, Universe Trade, and Jiangxi Liuling Rural Commercial Bank Co., LTD., Dated September 26, 2019
- 10.7 Form of Sales and Distribution Agreement by and Between Universe Trade and Customers
- 21.1 Subsidiaries
- 23.1 Consent of Friedman LLP
- 99.1 Code of Business Conduct and Ethics of the Registrant
- 99.2 Opinion of Allbright Law Offices, People's Republic of China Counsel to the Registrant, Regarding Certain PRC Law Matters
- 99.3 Consent of Frost and Sullivan
- 99.4 Industry Report by Frost and Sullivan
- 99.5 Consent of Jiawen Pang
- 99.6 Consent of Yongping Yu
- 99.7 Consent of Ding Zheng
- 24 Mar 21 424B4 Prospectus supplement with pricing info
- 23 Mar 21 EFFECT Notice of effectiveness
- 10 Mar 21 F-1/A Registration statement (foreign) (amended)
- 1 Mar 21 FWP Free writing prospectus
- 1 Mar 21 FWP Free writing prospectus
- 24 Feb 21 F-1/A Registration statement (foreign) (amended)
- 10 Dec 20 FWP Free writing prospectus
- 2 Dec 20 F-1/A Registration statement (foreign) (amended)
- 17 Nov 20 F-1/A Registration statement (foreign) (amended)
- 23 Sep 20 FWP Free writing prospectus
-
17 Aug 20 F-1 Registration statement (foreign)
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this amendment to the Registration Statement on Form F-1 of Universe Pharmaceuticals Inc. of our report dated April 24, 2020, except for Note 2 as to which the date is June 12, 2020 and Notes 11 and 14 as to which the date is August 17, 2020, with respect to the consolidated balance sheets of Universe Pharmaceuticals Inc. as of September 30, 2019 and 2018, and the related consolidated statements of income and comprehensive income, changes in shareholders’ equity and cash flows for each of the years in the two-year period ended September 30, 2019, included in this Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such Registration Statement.
/s/ Friedman LLP | |
New York, New York | |
August 17, 2020 |